Publications
Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers University of Antwerp
Frontal lobe 1H MR spectroscopy in asymptomatic and symptomatic MAPT mutation carriers University of Antwerp
The gametocytocidal efficacy of different single doses of primaquine with dihydroartemisinin-piperaquine in asymptomatic parasite carriers in The Gambia: a randomized controlled trial Institute of Tropical Medicine University of Antwerp
Background: Asymptomatic low-density gametocyte carriers represent the majority of malaria-infected individuals. However, the impact of recommended treatment with single low dose of primaquine and an artemisinin-based combination therapy to reduce transmission in this group is unknown.
Methods: This was a four-arm, open label, randomized controlled trial comparing the effect of dihydroartemisinin-piperaquine (DHAP) alone or combined ...
The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM) Institute of Tropical Medicine University of Antwerp
An interferon-gamma ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 Tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population Institute of Tropical Medicine
Rates of lobar atrophy in asymptomatic MAPT mutation carriers University of Antwerp
High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations Vrije Universiteit Brussel
Hereditary paraganglioma is a benign tumor syndrome with an age-dependent penetrance. Carriers of germline mutations in the SDHB or SDHD genes may develop parasympathetic paragangliomas in the head and neck region or sympathetic catecholamine-secreting abdominal and thoracic paragangliomas (pheochromocytomas). In this study, we aimed to establish paraganglioma risk in 101 asymptomatic germline mutation carriers and evaluate the results of our ...